Learning from Covid 19 in a level 1 oral and maxillofacial trauma centre - Insights for the future.

The coronavirus disease 2019 caused by the Severe Acute Respiratory Syndrome Coronavirus-2 has resulted in many confirmed cases around the world. Sars-CoV-2 remains viable and infectious in aerosols dispersed in air and is viable on surfaces up to several days. Symptomatic patients are the main reservoir for transmission.

Scan and Learn: Quick Response Code Enabled Museum for Mobile Learning of Anatomy and Pathology.

In the past, medical museums played a significant role in anatomy and pathology training. The attraction of medical museums has declined recently due to the emergence of information technology and innovative medical curricula. An innovative mobile learning platform has been developed using quick response (QR) codes for the museum specimens at the Lee Kong Chain School of Medicine, Singapore.

The PDA and the oral maxillofacial surgeon.

The personal digital assistant (PDA) offers clinicians the ability to enter and manage clinical information at the point of care. The first part of this series examined the oral medicine and surgery resources available on the Internet. This article discusses the possibilities of PDA technology, in conjunction with the Internet, for oral maxillofacial surgeons to enhance their clinical practice.

Increased synaptosomal [3H] GABA uptake in the rat brainstem after facial carrageenan injections.

The aim of the present study was to quantify synaptosomal [(3)H] gamma aminobutyric acid (GABA) uptake in the rat brainstem after facial carrageenan injections. Synaptosomal preparations from the brainstem of rats that had received one or four facial carrageenan injections showed greater GABA binding on the side of the brainstem ipsilateral to the carrageenan injection than on the contralateral side when compared to saline injected controls. In contrast, no difference in GABA binding between the injected and contralateral sides was observed in the same synaptosomal preparations that had been treated with GABA uptake inhibitors NNC-711, beta-alanine, or nipecotic acid.